Table 3.

Detailed distribution of copy number variations detected in 66 intrahepatic cholangiocarcinomas. Related to Fig. 2.

Gene	Poor		Good		Total		p-value*
	33	[%]	33	[%]	66	[%]
APC	2	[6.1]	1	[3.0]	3	[4.5]	—
ARID1A	3	[9.1]	5	[15.2]	8	[12.1]	—
CDKN2A	12	[36.4]	12	[36.4]	24	[36.4]	—
CCND1	9	[27.3]	8	[24.2]	17	[25.8]	—
EGFR	1	[3.0]	1	[3.0]	2	[3.0]	—
EPHA7	4	[12.1]	6	[18.2]	10	[15.2]	—
ERBB2	4	[12.1]	5	[15.2]	9	[13.6]	—
FGFR3	9	[27.3]	5	[15.2]	14	[21.2]	—
FHIT	8	[24.2]	11	[33.3]	19	[28.8]	—
KRAS	8	[24.2]	9	[27.3]	17	[25.8]	—
MET	11	[33.3]	5	[15.2]	16	[24.2]	0.15
MYC	10	[30.0]	5	[15.2]	15	[22.7]	0.24
PTEN	5	[15.2]	5	[15.2]	10	[15.2]	—
RB1	2	[6.1]			2	[3.0]	—
ROS	1	[3.0]	3	[9.1]	4	[6.1]	—
SMAD4	4	[12.1]	4	[12.1]	8	[12.1]	—
SRC	8	[24.2]	10	[30.3]	18	[27.3]	—
TP53	7	[21.2]			7	[10.6]	0.024

^*Fisher test for multiple comparison was used as appropriated.